Endeavor

DEVICE4 trials

Sponsors

VA Pittsburgh Healthcare System, Medtronic Vascular, Seung-Jung Park, Evald Hoej Christiansen

Conditions

Coronary Artery DiseaseIschemic Heart DiseaseWheelchair Users

Phase 2

Development of a Collapsible Folding Manual Wheelchair

CompletedNCT00283296

VA Pittsburgh Healthcare SystemWheelchair Users

Start: 2004-01-31End: 2011-04-30Updated: 2015-01-06

Phase 3

Randomized Clinical Comparison of the Endeavor and the Cypher Coronary Stents in Non-selected Angina Pectoris Patients

CompletedNCT00660478

Evald Hoej ChristiansenIschemic Heart Disease

Start: 2006-01-31End: 2009-10-31Updated: 2013-08-29

Phase 4

Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent and PacliTaxel-Eluting Stent for Coronary Lesions

CompletedNCT00418067

Seung-Jung ParkCoronary Artery Disease

Start: 2006-10-31End: 2009-01-31Updated: 2012-08-21

Unknown Phase

The ENDEAVOR Pharmacokinetic (PK) Registry: The Medtronic Endeavor Drug Eluting Coronary Stent System

CompletedNCT00314275

Medtronic VascularCoronary Artery Disease

Start: 2006-01-31End: 2011-08-31Updated: 2012-04-20

Related Papers

Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial.

2014-03-1482 citations

3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents.

2012-08-0129 citations

Comparison of zotarolimus-eluting stents with sirolimus-eluting and paclitaxel-eluting stents: intimal hyperplasia and vascular changes assessed by volumetric intravascular ultrasound analysis.

2011-03-017 citations

Comparison of zotarolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization: the ZEST (comparison of the efficacy and safety of zotarolimus-eluting stent with sirolimus-eluting and paclitaxel-eluting stent for coronary lesions) randomized trial.

2010-10-01102 citations

Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial.

2010-03-16147 citations